Podcast
MSL Talk: Tom Caravela
What Makes KOLs Tick
Summary
In this episode, Deanna Murray joins to delve into the intricacies of engaging with Key Opinion Leaders (KOLs). The discussion begins with understanding KOL motivations and the importance of aligning with their needs. Deanna highlights the significance of proactive strategies, effective pre-call planning, and questioning techniques. The conversation explores innovative approaches to KOL engagement, emphasizing problem-solving and tailoring presentations. The role of MSLs in rare diseases and adapting to hybrid interactions post-COVID are also covered. The episode concludes with performance enhancement tips and an acknowledgment of the sponsor, High Five Challenge.
Deanna Murray, MSL Team Lead at Sarepta Pharmaceuticals discusses what makes KOLs tick and how to be a more effective MSL
Deanna shares…
👉 How to be a more proactive MSL vs reactive
👉 What questions MSLs should be asking their KOLs
👉 Why pre-call planning is so important
👉 How to determine WHAT you should be presenting to your KOLs
👉 Creative ways to get face time with your KOLs
Key Opinion Leaders, KOL engagement strategies, proactive MSL techniques, rare disease MSL roles, hybrid interaction post-COVID
Related Topics
You May Also Like
MSL Talk: Tom Caravela
Podcast
MSL Talk: Tom Caravela, Linda Taylor
The 3 “Knows” of Effective Scientific Communication
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO